Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Bremaud

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature Communications|November 1, 2023
HIV-1 diverts cortical actin for particle assembly and releaseRayane Dibsy, Erwan Bremaud, Johnson Mak, et al.
Biophysical Journal|January 12, 2023
Quantifying membrane binding and diffusion with fluorescence correlation spectroscopy diffusion lawsAnita Mouttou, Erwan Bremaud, Julien Noero, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
SARS-CoV-2 spike protein-associated sialoglycoconjugates induce nanoscale filipodia to facilitate micro-size platelet clottingAblikim Baqi, Ainur Sanaubarova, Belinda L Spillings, et al.
Iscience|September 12, 2022
The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signalingEmmanuel Laplantine, Christine Chable-Bessia, Anne Oudin, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature Communications|November 1, 2023
HIV-1 diverts cortical actin for particle assembly and releaseRayane Dibsy, Erwan Bremaud, Johnson Mak, et al.
Biophysical Journal|January 12, 2023
Quantifying membrane binding and diffusion with fluorescence correlation spectroscopy diffusion lawsAnita Mouttou, Erwan Bremaud, Julien Noero, et al.
Biorxiv : the Preprint Server for Biology|May 4, 2026
SARS-CoV-2 spike protein-associated sialoglycoconjugates induce nanoscale filipodia to facilitate micro-size platelet clottingAblikim Baqi, Ainur Sanaubarova, Belinda L Spillings, et al.
Iscience|September 12, 2022
The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signalingEmmanuel Laplantine, Christine Chable-Bessia, Anne Oudin, et al.
Pageof 1